The United States stem cell market is predicted to project a CAGR of 7.59%, during the forecast years of 2021 to 2025. The country’s market growth is driven by factors like the increased number of cancer cases, the improved healthcare infrastructure, the growing focus on research and development activities, and stem cell therapy as a promising approach to treat COVID-19.

UNITED STATES STEM CELL MARKET FORECAST 2021-2025

United States Stem Cell Market by Therapeutic Application (Orthopedic Treatments, Injuries and Wounds, Oncology Disorders, Cardiovascular Disorders, Neurological Disorders, Diabetes, Other Therapeutic Applications) by Product (Adult Stem Cell (Hematopoietic Stem Cell, Neural Stem, Umbilical Cord Stem Cell, Mesenchymal Stem Cell, Dental Stem Cell), Human Embryonic Stem Cell, Pluripotent, Mouse/rat Neural) by Technology (Acquisition (Stem Cell Bone Marrow Market, Stem Cell Apheresis, Stem Cell Umbilical Cord), Cryopreservation, Expansion and Sub-culture, Production (Stem Cell Culture, Therapeutic Cloning, Ivf)) by Application (Regenerative Medicine, Drug Discovery and Development) by Treatment Type (Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy, Syngeneic Stem Cell Therapy)

Request free sample

Report Summary

The United States stem cell market is predicted to project a CAGR of 7.59%, during the forecast years of 2021 to 2025. The country’s market growth is driven by factors like the increased number of cancer cases, the improved healthcare infrastructure, the growing focus on research and development activities, and stem cell therapy as a promising approach to treat COVID-19.

To learn more about this report, request a free sample copy

The growing number of cancer cases in the United States generates numerous opportunities for enterprises operating across the country’s market. Moreover, key players continue to focus on introducing new stem cell therapies through consistent research and development endeavors. According to the National Cancer Institute (NCI), the United States’ cancer care expenditure is anticipated to reach nearly $156 billion, in 2020, thereby bolstering the country’s market growth. Likewise, the National Eye Institute’s researchers launched a clinical trial in December 2019. The trial entailed testing the safety of a new patient-oriented stem cell therapy to treat the advanced dry form of age-related macular degeneration (AMD), termed geographic atrophy. This condition is among the leading causes of vision loss among individuals aged 65 and over.

The COVID-19 outbreak also plays a crucial role in augmenting the United States’ stem cell market, owing to research activities associated with the virus’ treatment. Besides, stem cell therapy is also a prospective and promising approach towards treating the novel coronavirus. Hence, these factors are expected to drive market growth, during the forecast period.

With its headquarters in the United States, Corning Inc primarily manufactures and commercializes specialty gases, ceramic, and related materials, across the Asia Pacific, Europe, and North America, among other regions. The company operates through five significant segments, including, life science, environmental technologies, display technology, specialty material, and optical communication.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Table of Contents

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • COUNTRY SNAPSHOT
      • COUNTRY ANALYSIS
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
    3. KEY ANALYTICS
      •    PORTER’S FIVE FORCE ANALYSIS
        • THREAT OF NEW ENTRY
        • THREAT OF SUBSTITUTION
        • BUYER’S POWER
        • SUPPLIER’S POWER
        • COMPETITIVE RIVALRY
      • IMPACT OF COVID-19 ON STEM CELL MARKET
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
      • HISTORY OF STEM CELL
      • REGULATORY FRAMEWORK
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY INVESTMENT INSIGHTS
    4. MARKET BY THERAPEUTIC APPLICATION
      • ORTHOPEDIC TREATMENTS
      • INJURIES AND WOUNDS
      • ONCOLOGY DISORDERS
      • CARDIOVASCULAR DISORDERS
      • NEUROLOGICAL DISORDERS
      • DIABETES
      • OTHER THERAPEUTIC APPLICATIONS
    5. MARKET BY PRODUCT
      •    ADULT STEM CELL
        • HEMATOPOIETIC STEM CELL
        • NEURAL STEM
        • UMBILICAL CORD STEM CELL
        • MESENCHYMAL STEM CELL
        • DENTAL STEM CELL
      • HUMAN EMBRYONIC STEM CELL
      • PLURIPOTENT
      • MOUSE/RAT NEURAL
    6. MARKET BY TECHNOLOGY
      •    ACQUISITION
        • STEM CELL BONE MARROW MARKET
        • STEM CELL APHERESIS
        • STEM CELL UMBILICAL CORD
      • CRYOPRESERVATION
      • EXPANSION AND SUB-CULTURE
      •    PRODUCTION
        • STEM CELL CULTURE
        • THERAPEUTIC CLONING
        • IVF
    1. MARKET BY APPLICATION
      • REGENERATIVE MEDICINE
      • DRUG DISCOVERY AND DEVELOPMENT
    2. MARKET BY TREATMENT TYPE
      • ALLOGENEIC STEM CELL THERAPY
      • AUTOLOGIC STEM CELL THERAPY
      • SYNGENEIC STEM CELL THERAPY
    3. COMPETITIVE LANDSCAPE
      •    KEY STRATEGIC DEVELOPMENTS
        • MERGER & ACQUISITIONS
        • PRODUCT LAUNCH & DEVELOPMENTS
        • PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
        • BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
      •    COMPANY PROFILE
        • BECTON, DICKINSON AND COMPANY (BD)
        • CORNING INC
        • GE HEALTHCARE
        • STEMCELL TECHNOLOGIES
        • THERMO FISHER SCIENTIFIC INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – STEM CELL

    TABLE 2: UNITED STATES STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: UNITED STATES STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2021-2025 (IN $ MILLION)

    TABLE 4: UNITED STATES STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: UNITED STATES STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2021-2025 (IN $ MILLION)

    TABLE 6: UNITED STATES ADULT STEM CELL MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: UNITED STATES ADULT STEM CELL MARKET, BY TYPES, FORECAST YEARS, 2021-2025 (IN $ MILLION)

    TABLE 8: UNITED STATES STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: UNITED STATES STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2025 (IN $ MILLION)

    TABLE 10: UNITED STATES ACQUISITION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: UNITED STATES ACQUISITION MARKET, BY TYPES, FORECAST YEARS, 2021-2025 (IN $ MILLION)

    TABLE 12: UNITED STATES PRODUCTION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: UNITED STATES PRODUCTION MARKET, BY TYPES, FORECAST YEARS, 2021-2025 (IN $ MILLION)

    TABLE 14: UNITED STATES STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: UNITED STATES STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2021-2025 (IN $ MILLION)

    TABLE 16: UNITED STATES STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 17: UNITED STATES STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2021-2025 (IN $ MILLION)

    LIST OF FIGURES

    FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 2: OPPORTUNITY MATRIX

    FIGURE 3: VENDOR LANDSCAPE

    FIGURE 4: KEY INVESTMENT INSIGHTS

    FIGURE 5: UNITED STATES STEM CELL MARKET, BY THERAPEUTIC APPLICATION, IN 2020

    FIGURE 6: UNITED STATES STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2025 (IN $ MILLION)

    FIGURE 7: UNITED STATES STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2025 (IN $ MILLION)

    FIGURE 8: UNITED STATES STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2025 (IN $ MILLION)

    FIGURE 9: UNITED STATES STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2025 (IN $ MILLION)

    FIGURE 10: UNITED STATES STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2025 (IN $ MILLION)

    FIGURE 11: UNITED STATES STEM CELL MARKET, BY DIABETES, 2021-2025 (IN $ MILLION)

    FIGURE 12: UNITED STATES STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2025 (IN $ MILLION)

    FIGURE 13: UNITED STATES STEM CELL MARKET, BY PRODUCT, IN 2020

    FIGURE 14: UNITED STATES STEM CELL MARKET, BY ADULT STEM CELL, 2021-2025 (IN $ MILLION)

    FIGURE 15: UNITED STATES STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2025 (IN $ MILLION)

    FIGURE 16: UNITED STATES STEM CELL MARKET, BY NEURAL STEM, 2021-2025 (IN $ MILLION)

    FIGURE 17: UNITED STATES STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2025 (IN $ MILLION)

    FIGURE 18: UNITED STATES STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2025 (IN $ MILLION)

    FIGURE 19: UNITED STATES STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2025 (IN $ MILLION)

    FIGURE 20: UNITED STATES STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2025 (IN $ MILLION)

    FIGURE 21: UNITED STATES STEM CELL MARKET, BY PLURIPOTENT, 2021-2025 (IN $ MILLION)

    FIGURE 22: UNITED STATES STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2025 (IN $ MILLION)

    FIGURE 23: UNITED STATES STEM CELL MARKET, BY TECHNOLOGY, IN 2020

    FIGURE 24: UNITED STATES STEM CELL MARKET, BY ACQUISITION, 2021-2025 (IN $ MILLION)

    FIGURE 25: UNITED STATES STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2025 (IN $ MILLION)

    FIGURE 26: UNITED STATES STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2025 (IN $ MILLION)

    FIGURE 27: UNITED STATES STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2025 (IN $ MILLION)

    FIGURE 28: UNITED STATES STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2025 (IN $ MILLION)

    FIGURE 29: UNITED STATES STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2025 (IN $ MILLION)

    FIGURE 30: UNITED STATES STEM CELL MARKET, BY PRODUCTION, 2021-2025 (IN $ MILLION)

    FIGURE 31: UNITED STATES STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2025 (IN $ MILLION)

    FIGURE 32: UNITED STATES STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2025 (IN $ MILLION)

    FIGURE 33: UNITED STATES STEM CELL MARKET, BY IVF, 2021-2025 (IN $ MILLION)

    FIGURE 34: UNITED STATES STEM CELL MARKET, BY APPLICATION, IN 2020

    FIGURE 35: UNITED STATES STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2025 (IN $ MILLION)

    FIGURE 36: UNITED STATES STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2025 (IN $ MILLION)

    FIGURE 37: UNITED STATES STEM CELL MARKET, BY TREATMENT TYPE, IN 2020

    FIGURE 38: UNITED STATES STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2025 (IN $ MILLION)

    FIGURE 39: UNITED STATES STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2025 (IN $ MILLION)

    FIGURE 40: UNITED STATES STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2025 (IN $ MILLION)

    Segmentation

    1. MARKET BY THERAPEUTIC APPLICATION
      • ORTHOPEDIC TREATMENTS
      • INJURIES AND WOUNDS
      • ONCOLOGY DISORDERS
      • CARDIOVASCULAR DISORDERS
      • NEUROLOGICAL DISORDERS
      • DIABETES
      • OTHER THERAPEUTIC APPLICATIONS
    2. MARKET BY PRODUCT
      •    ADULT STEM CELL
        • HEMATOPOIETIC STEM CELL
        • NEURAL STEM
        • UMBILICAL CORD STEM CELL
        • MESENCHYMAL STEM CELL
        • DENTAL STEM CELL
      • HUMAN EMBRYONIC STEM CELL
      • PLURIPOTENT
      • MOUSE/RAT NEURAL
    3. MARKET BY TECHNOLOGY
      •    ACQUISITION
        • STEM CELL BONE MARROW MARKET
        • STEM CELL APHERESIS
        • STEM CELL UMBILICAL CORD
      • CRYOPRESERVATION
      • EXPANSION AND SUB-CULTURE
      •    PRODUCTION
        • STEM CELL CULTURE
        • THERAPEUTIC CLONING
        • IVF
    1. MARKET BY APPLICATION
      • REGENERATIVE MEDICINE
      • DRUG DISCOVERY AND DEVELOPMENT
    2. MARKET BY TREATMENT TYPE
      • ALLOGENEIC STEM CELL THERAPY
      • AUTOLOGIC STEM CELL THERAPY
      • SYNGENEIC STEM CELL THERAPY

    Request Free Sample

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type

      Get In Touch

      Inquire Before Buying

      Customization

      Inkwood Research delivers customized reports as per the client's requirement to provide them with an edge in the competitive market

      Request Customization

      RELATED REPORTS